NEU — Neuren Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Neuren Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36.8	40.2	229	222	296
Net Total Accounts Receivable
Net Total Receivables	1.42	1.09	14.4	175	26.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40	43.2	247	399	332
Net Property, Plant And Equipment	0.012	0.021	0.043	0.031	0.045
Other Long Term Assets
Total Assets	40.1	43.3	248	410	343
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.803	1.68	42.8	45.8	4.34
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.803	1.68	42.8	45.8	4.41
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	39.3	41.6	205	364	338
Total Liabilities & Shareholders' Equity	40.1	43.3	248	410	343
Total Common Shares Outstanding